ReviewMedical & biological engineering & computing2025
Pan-Ret: a semi-supervised framework for scalable detection of pan-retinal diseases.
Review in Medical & biological engineering & computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It has been shown in recent years that a range of optical diseases have early manifestation in retinal fundus images. It is becoming increasingly important to separate the regions of interest (RoI) upfront in the automated classification pipeline in order to ensure the alignment of the disease diagnosis with clinically relevant visual features. In this work, we introduce Pan-Ret, a semi-supervised framework which starts with locating the abnormalities in the biomedically relevant RoIs of a retinal image in an "annotation-agnostic" fashion. It does so by leveraging an anomaly detection setup using parallel autoencoders that are trained only on healthy population initially. Then, the anomalous images are separated based on the RoIs using a fully interpretable classifier like support vector machine (SVM). Experimental results show that the proposed approach yields an overall F1-score of 0.95 and 0.96 in detecting abnormalities on two different public datasets covering a diverse range of retinal diseases including diabetic retinopathy, hypertensive retinopathy, glaucoma, age-related macular degeneration, and several more in a staged manner. Thus, the work presents a milestone towards a pan-retinal disease diagnostic pipeline that can not only cater to the current set of disease classes, but has the capacity of adding further classes down the line. This is due to an anomaly detection style one-class learning setup of the deep autoencoder piece of the proposed pipeline, thus improving the generalizability of this approach compared to usual fully supervised competitors. This is also expected to increase the practical translational potential of Pan-Ret in a real-life scalable clinical setting.
Indexed as
Identifiers
39672991What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.